Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (261-270 of 825) with videos related to

Pageof 83
Sort By:
The Journal of Experimental Medicine|March 1, 1978
Induction of partial chimerism in nonirradiated B-lymphocyte-deficient CBA/N miceD Volf, L L Sensenbrenner, S J Sharkis, et al.
Cryobiology|December 1, 1980
Determination of surface immunoglobulin density on frozen-thawed mononuclear cells analyzed by the fluorescence-activated cell sorterR B Slease, D M Strong, R Wister, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1979
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locusB Subbarao, A Ahmed, W E Paul, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephromaH I Scher, A Yagoda, T Ahmed, et al.
Cancer Research|May 3, 2003
Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to TaxolDavid B Solit, Andrea D Basso, Adam B Olshen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Prostate cancer clinical trial end points: "RECIST"ing a step backwardsHoward I Scher, Michael J Morris, William K Kelly, et al.
Cancer|December 15, 1992
Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapyD P Petrylak, H I Scher, Z Li, et al.
Acta Oncologica (Stockholm, Sweden)|December 4, 2003
Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elementsGunnar Steineck, Victor Reuter, William K Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancerW K Kelly, T Curley, C Leibretz, et al.
Urology|May 1, 1996
Acid phosphatase: defining a role in androgen-independent prostate cancerG Steineck, W K Kelly, M Mazumdar, et al.
Pageof 83

Showing results (261-270 of 825) with videos related to

Sort By:
Pageof 83
The Journal of Experimental Medicine|March 1, 1978
Induction of partial chimerism in nonirradiated B-lymphocyte-deficient CBA/N miceD Volf, L L Sensenbrenner, S J Sharkis, et al.
Cryobiology|December 1, 1980
Determination of surface immunoglobulin density on frozen-thawed mononuclear cells analyzed by the fluorescence-activated cell sorterR B Slease, D M Strong, R Wister, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1979
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locusB Subbarao, A Ahmed, W E Paul, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephromaH I Scher, A Yagoda, T Ahmed, et al.
Cancer Research|May 3, 2003
Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to TaxolDavid B Solit, Andrea D Basso, Adam B Olshen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Prostate cancer clinical trial end points: "RECIST"ing a step backwardsHoward I Scher, Michael J Morris, William K Kelly, et al.
Cancer|December 15, 1992
Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapyD P Petrylak, H I Scher, Z Li, et al.
Acta Oncologica (Stockholm, Sweden)|December 4, 2003
Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elementsGunnar Steineck, Victor Reuter, William K Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancerW K Kelly, T Curley, C Leibretz, et al.
Urology|May 1, 1996
Acid phosphatase: defining a role in androgen-independent prostate cancerG Steineck, W K Kelly, M Mazumdar, et al.
Pageof 83